• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

MilliporeSigma

Ireland pharma Ireland biopharma Ireland manufacturing drug manufacturing
Pharma

Ireland's drug production hub status intact amid US trade tumult

Amid an influx of U.S. investments, geopolitical uncertainties support the need for manufacturing projects elsewhere, IDA Ireland's Rory Mullen said.
Fraiser Kansteiner Mar 3, 2026 4:27pm
Merck KGaA MilliporeSigma US

MilliporeSigma debuts new plant as part of €440M investment

Sep 18, 2025 8:30am
MilliporeSigma facility

MilliporeSigma, Simtra combine in ADC manufacturing partnership

Jun 11, 2025 11:15am
Merck KGaA MilliporeSigma US

MilliporeSigma's production push rolls with $76M ADC investment

Oct 29, 2024 10:33am
Merck KGaA MilliporeSigma US

MilliporeSigma plugs €62M into new quality control building

Jun 14, 2024 10:00am
MilliporeSigma facility

Merck KGaA buys out gene therapy specialist Mirus Bio for $600M

May 23, 2024 8:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings